Nicorette launch features Facebook contest with Dr. Drew

Share this article:
Nicorette launch features Facebook contest with Dr. Drew
Nicorette launch features Facebook contest with Dr. Drew

GlaxoSmithKline is launching a Nicorette lozenge with a new iteration of the “Quitting Sucks” ad campaign and a Facebook contest starring TV shrink Dr. Drew Pinsky.

The Nicorette Mini Lozenge features a “discreet pocket-size vial,” not dissimilar to the packaging for Mentos. GSK boasts that the lozenge, GSK's first, “dissolves up to three times faster than other stop smoking lozenges and can double a smoker's chances of successfully quitting versus placebo.”

In the TV ad, by TBWA\Chiat\Day, a man in the throes of a nicotine fit sits on a pier, gazing dully out at the water and mumbling “cigarette, cigarette, cigarette.” He proceeds to do so after a shark jumps out of the water and latches onto his arm, oblivious to all but his addiction until he pops a Nicorette Mini Lozenge, whereupon he screams “Shark!” and punches the critter with his free hand.

The company has built a Facebook page for the brand and is launching a “Mini Moments” contest, where smokers can submit their top reason for wanting to quit for a chance to win a trip to LA for a taping of Dr. Pinsky's Loveline and a free course of the lozenges. The page also features short video clips with Pinsky's tips for quitting. Though best known for Loveline, Pinsky is an addiction expert who has featured in the VH1 shows Celebrity Rehab and Sober House.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...